Clinical Trials Browser

Phase 1/2 × oblimersen × Lymphoid × Clear all

NCT00062244 2013-06-04

Oblimersen in Treating Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia

Phase 1/2 Completed

Waldenstrom Macroglobulinemia

NCT00086944 2013-01-24

Oblimersen, Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

Phase 1/2 Completed

Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell